Emcure Pharmaceuticals announced that Mr. Kuber Jagdale, President – API Business, superannuated from the company on June 30, 2026. Consequently, he ceased to be a Senior Management Personnel as per Regulation 16(1)(d) of the SEBI Listing Regulations. The cessation is on account of superannuation and does not constitute a resignation.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that the submission of a resignation letter is not applicable in this instance.

The following table details the particulars of the change in senior management personnel:

The intimation was submitted to the National Stock Exchange of India Limited and BSE Limited on June 30, 2026. Amruta Amit Yangalwar, Company Secretary & Compliance Officer, signed the disclosure on behalf of Emcure Pharmaceuticals Limited.

Emcure Pharmaceuticals has confirmed that its promoters and persons acting in concert did not create any fresh encumbrance on their equity shareholdings during the financial year ended March 31, 2026. The disclosure, made to the National Stock Exchange of India Limited and BSE Limited, aims to comply with regulatory transparency requirements regarding share pledges by key shareholders.

The declaration, signed by Promoters Satish Mehta, Sunil Mehta, Samit Mehta, and Namita Thapar, confirms that no new pledges were made directly or indirectly by the promoter group during FY26. However, the filing notes that an existing encumbrance involving Mrs. Smita Paresh Shah, a member of the promoter group, remains active. She had pledged 60,000 equity shares during the financial year 2024-25, and these shares continue to remain pledged as of March 31, 2026.

Promoter Group Details

The filing identified the individuals and entities classified as promoters and persons acting in concert. The list includes four individual promoters and 37 entities categorized under the promoter group, comprising family members, private limited companies, and trusts.

The list of entities includes firms such as Uth Beverage Factory Private Limited, Thapar Ventures Private Limited, and Avet Lifesciences Private Limited. Trusts such as Indus Trust, Unity Trust, and Himalayan Trust are also included within the promoter group definition.

Regulatory Compliance

The disclosure was submitted pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters to declare any encumbrance on shares held by them or persons acting in concert. The company has requested the exchanges to place the information on their records.